(Q48362877)

English

In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.

scientific article published in January 1993

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

multiple sclerosis

0 references

blood–brain barrier

1 reference

based on heuristic

inferred from title

Maria Rosa Ciardi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

author name string

M K Sharief

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

R Hentges

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

E J Thompson

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

240

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

46-50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Penetration of recombinant interleukin-2 across the blood-cerebrospinal fluid barrier.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The blood-brain barrier redefined

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2-activated human killer lymphocytes but not their secreted products mediate increase in albumin flux across cultured endothelial monolayers. Implications for vascular leak syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Calculating confidence intervals for some non-parametric analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 receptor levels indicating relapse in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum-CSF protein gradients, the blood-GSF barrier and the local immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of interleukin-2 in cerebrospinal fluid by a sensitive enzyme-linked immunosorbent assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of microvascular endothelial cells to biological response modifiers

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Infiltrative and cytolytic activities of lymphokine-activated killer (LAK) cells against a human glioma mass: ultrastructural analysis using a three-dimensional multicellular spheroid model].

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential central nervous system responses following single and multiple recombinant interleukin-2 infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nature of inflammatory components during demyelination in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lesion of multiple sclerosis: imaging of acute and chronic stages

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sclerosis or blood-brain barrier disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute fatal leukoencephalopathy after interleukin-2 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of interleukin 2 receptors on human endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient focal neurologic deficits complicating interleukin-2 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial cell lysis induced by lymphokine-activated human peripheral blood mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood-brain barrier dysfunction in cats following recombinant interleukin-2 infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8423463

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00838446

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8423463%20AND%20SRC:MED&resulttype=core&format=json

12 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48362877&oldid=2209379558"